Comparing tumor-infiltrating CD8+ T cells with PBMC-derived, identified CX3CR1high and CX3CR1int CD8+ T cells with effector and memory phenotype, respectively, enriched in blood but absent in the iTME. The gene discussed is CD8A; the disease is neoplasm.